<DOC>
	<DOC>NCT01059357</DOC>
	<brief_summary>The purpose of this study is to conduct a pilot single-arm to assess transoral robotic surgery (TORS) for oral and laryngopharyngeal benign and malignant lesions using the Da Vinci Robotic Surgical System.</brief_summary>
	<brief_title>Transoral Robotic Surgery (TORS) for Oral and Laryngopharyngeal Lesions Using Da Vinci Robotic Surgical System</brief_title>
	<detailed_description>Patients are going to be evaluated in their usual regular clinical follow ups starting with preoperative first visit, 3 weeks, 3 months and 6 months postoperatively with a Quality of Life survey (Head and Neck Cancer Inventory, HNCI-QOLQ).</detailed_description>
	<mesh_term>Head and Neck Neoplasms</mesh_term>
	<criteria>Patient must present with indications for diagnostic or therapeutic approaches for benign and malignant diseases of the oral cavity or laryngopharynx (including the neoplastic lesions of the tongue, tongue base, retromolar trigone, tonsils, palate, posterior and lateral pharynx, glottic, supraglottic and subglottic larynx) Patients must have adequate transoral exposure of the oral cavity and laryngopharynx for TORS instrumentation Unexplained fever and/or untreated, active infection Patient pregnancy Previous head and neck surgery precluding transoral/robotic procedures The presence of medical conditions contraindicating general anesthesia or transoral surgical approaches</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>